Diabetic Foot Ulcer Treatment, Companies, Market Trends

A Diabetic Foot Ulcer (DFU) is an open sore or wound that occurs in patients with diabetes and is commonly located on the bottom of the foot. The average duration of diabetes before ulceration is less than ten years.

Diabetic Foot Ulcer is one of the most significant and devastating complications of poorly controlled diabetes (type 1 and type 2) and probably the major component of the diabetic foot. In most DFU patients, peripheral neuropathy and peripheral arterial disease (PAD) play a central role, and people who develop foot ulcers lose the ability to feel pain in the affected area.

Diabetic Foot Ulcer Epidemiological Segmentation

Total Prevalent Cases of DFU
Total Diagnosed Cases of DFU
Gender-specific Cases of DFU
Age-Specific Cases of DFU
DFU cases by severity/ chronicity of wound
Treated cases of DFU

Diabetic Foot Ulcer Epidemiology

The total treated cases of DFU in the 7MM were 1,973,895.
The total number of Diabetic Foot Ulcers prevalent cases in the United States was found to be 4,551,498.
The total DFU prevalent cases in EU-5 countries were 1,274,933.
In Japan, the total number of Diabetic Foot Ulcer prevalent cases was observed to be 168,547.
The total gender-specific prevalent cases in the 7MM were 2,149,948 for males and 1,374,864 cases for females.

Diabetic Foot Ulcers Market

The therapeutic market of DFU in the seven major markets is expected to increase during the study period (2018–2030) with a CAGR of 17.0%.

Diabetic Foot Ulcers Market Drivers